News
$Petros Pharmaceuticals(PTPI.US$ Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results With Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (Avanafil)
Accesswire· 1 min ago
Utilization of the Company's proprietary Web App showed improved self-selection utilizing an embedded validated diagnostic questionnaire compared to a live interview furthering the Company's efforts to potentially create a first-ever Rx-to-OTC switch in the ED category
Accesswire· 1 min ago
Utilization of the Company's proprietary Web App showed improved self-selection utilizing an embedded validated diagnostic questionnaire compared to a live interview furthering the Company's efforts to potentially create a first-ever Rx-to-OTC switch in the ED category
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
